Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria - Is it time for a more individual approach?

Annals of Transplantation

Volumn 18, Issue 1, 2013, Pages 515-524

  Heinzow, Hauke Sebastian ^a   Brockmann, Jens G ^b   Köhler, Michael ^a   Wolters, Heiner H ^a   Senninger, Norbert ^a   Schmidt, Hartmut ^a   Meister, Tobias ^a,c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Department of Medicine II   (Germany)

Author keywords

Beyond Milan criteria; HCC; Hepatocellular carcinoma; Liver transplantation; STACE; Transarterial chemoembolization

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CISPLATIN; DOXORUBICIN; IODINATED POPPYSEED OIL;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CATHETER; CHEMOEMBOLIZATION; CHILD PUGH SCORE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FEVER; FOLLOW UP; GRAFT REJECTION; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MICROCATHETER; NAUSEA; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SUPRASELECTIVE TRANSARTERIAL CHEMOEMBOLIZATION; TREATMENT CONTRAINDICATION; TUMOR VOLUME; VOMITING;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; DOXORUBICIN; ETHIODIZED OIL; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PALLIATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84887241943     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.884018     Document Type: Article

References (30)

1. Pacholczyk M et al: Liver transplantation for HCV cirrhosis; cautious optimism after 10 years of experience. Ann Transplant, 2012; 17(4): 5-10
2. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology, 1998; 28(3): 751-55
3. Kim JM et al: Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation? Transplant Proc, 2010; 42(3): 821-24
4. Harada N et al: Surgical management of hepatocellular carcinoma in Child-Pugh class B cirrhotic patients: hepatic resection and/or microwave coagulation therapy versus living donor liver transplantation. Ann Transplant, 2012; 17(4): 11-20
5. Vogl TJ et al: Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications. Eur J Radiol, 2009; 72(3): 505-16
6. Chaparro M et al: Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents. Aliment Pharmacol Ther, 2008; 28(11-12): 1269-77
7. Kamath PS et al: A model to predict survival in patients with end-stage liver disease. Hepatology, 2001; 33(2): 464-70
8. Majno PE et al: Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg, 1997; 226(6): 688-701; discussion 701-3
9. Dharancy S et al: Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl, 2007; 13(5): 665-71
10. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology, 2003; 37(2): 429-42
11. Llovet JM et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet, 2002; 359(9319): 1734-39
12. Mazzaferro V et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med, 1996; 334(11): 693-99
13. Adler M et al: Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system. Liver Transpl, 2008; 14(4): 526-33
14. Yao FY et al: Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl, 2002; 8(9): 765-74
15. Fruhauf NR et al: Joint impact of donor and recipient parameters on the outcome of liver transplantation in Germany. Transplantation, 2011; 92(12): 1378-84
16. Bruix J et al: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol, 2001; 35(3): 421-30
17. Okuda K: Early recognition of hepatocellular carcinoma. Hepatology, 1986; 6(4): 729-38
18. Pugh RN et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973; 60(8): 646-49
19. Heinzow HS et al: Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma. Scand J Gastroenterol, 2011; 46(2): 201-10
20. Maleux G et al: Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions. Dig Dis, 2009; 27(2): 157-63
21. Therasse P et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst, 2000; 92(3): 205-16
22. Marelli L et al: Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol, 2007; 30(1): 6-25
23. Heresbach D et al: [Chemotherapy combined with Lipiodol. In vitro study of the kinetics of release of adriamycin]. Gastroenterol Clin Biol, 1989; 13(10): 775-78
24. Sakaguchi H et al: [Pharmacokinetic study of adriamycin in the emulsion mixed with lipiodoldifference resulting from composition and methods of preparation, and behavior after mesenteric arterial injection in rat]. Gan To Kagaku Ryoho, 1991; 18(8): 1349-55
25. Nakamura H et al: Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology, 1989; 170(3 Pt 1): 783-86
26. Llovet JM et al: Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst, 2008; 100(10): 698-711
27. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med, 1996; 15(4): 361-87
28. Sakamoto I et al: Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics, 1998; 18(3): 605-19
29. Yao FY et al: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 2001; 33(6): 1394-403
30. Mazzaferro V et al: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol, 2009; 10(1): 35-43